GRRMY.US Gerresheimer AG

Healthcare Health Care Equipment & Supplies USA Stocks
8.44 USD
Close of Nov 14, 2026
4.71 9.79
Market cap
USD 1.17B
P/E
-
P/B
1.10x
ROE
-41.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Feb 2026.

Is GRRMY.US undervalued?

Graham number

The Graham number of Gerresheimer AG cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Gerresheimer AG fundamental analysis

No fundamental analysis for Gerresheimer AG yet.

Gerresheimer AG stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Gerresheimer AG

Gerresheimer AG, together with its subsidiaries, provides drug containment solutions in Germany and internationally. The company operates through three divisions: Plastics & Devices, Primary Packaging Glass, and Advanced Technologies. It offers prefillable syringes, plastic and glass packaging solutions, vials, glass cartridges and ampoules, bottles and containers, and containers, bottles, caps, closures, applicators, and accessories; development, industrialization, and cont…

Full company profile